Global Peripheral Arterial Interventional Devices Market Growth 2025-2031

Publication ID:

LPI04253054

Publication Date:

April 25, 2025

Pages:

116

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Peripheral Arterial Interventional Devices market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
In China, key players of peripheral arterial interventional devices include Medtronic, Inc., BD, Boston Scientific Corporation, Abbott Laboratories, etc. Top five manufacturers hold a share over 83%. In terms of product, bare stent is the largest segment, with a share over 42%. And in terms of application, the largest application is lower limbs, with a share over 76%.
The 鈥淧eripheral Arterial Interventional Devices Industry Forecast鈥� looks at past sales and reviews total world Peripheral Arterial Interventional Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Peripheral Arterial Interventional Devices sales for 2025 through 2031. With Peripheral Arterial Interventional Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Arterial Interventional Devices industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Arterial Interventional Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peripheral Arterial Interventional Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Peripheral Arterial Interventional Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Arterial Interventional Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Arterial Interventional Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Arterial Interventional Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Drug-eluting Stent
Bare Stent
Ordinary Balloon
Drug-eluting Balloon
Special Balloon
Others
Segmentation by Application:
Lower Limbs
Renal Artery
Carotid Artery
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic, Inc.
BD
Boston Scientific Corporation
Abbott Laboratories
Cordis
Acotec
Biotronik
Terumo Corporation
Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd.
Cook Medical
Lepu Medical
Zylox-Tonbridge Medical Technology Co., Ltd.
LeoMed
LifeTech Scientific Corporation
Key Questions Addressed in this Report
What is the 10-year outlook for the global Peripheral Arterial Interventional Devices market?
What factors are driving Peripheral Arterial Interventional Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peripheral Arterial Interventional Devices market opportunities vary by end market size?
How does Peripheral Arterial Interventional Devices break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peripheral Arterial Interventional Devices Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Peripheral Arterial Interventional Devices by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Peripheral Arterial Interventional Devices by Country/Region, 2020, 2024 & 2031
2.2 Peripheral Arterial Interventional Devices Segment by Type
2.2.1 Drug-eluting Stent
2.2.2 Bare Stent
2.2.3 Ordinary Balloon
2.2.4 Drug-eluting Balloon
2.2.5 Special Balloon
2.2.6 Others
2.3 Peripheral Arterial Interventional Devices Sales by Type
2.3.1 Global Peripheral Arterial Interventional Devices Sales Market Share by Type (2020-2025)
2.3.2 Global Peripheral Arterial Interventional Devices Revenue and Market Share by Type (2020-2025)
2.3.3 Global Peripheral Arterial Interventional Devices Sale Price by Type (2020-2025)
2.4 Peripheral Arterial Interventional Devices Segment by Application
2.4.1 Lower Limbs
2.4.2 Renal Artery
2.4.3 Carotid Artery
2.5 Peripheral Arterial Interventional Devices Sales by Application
2.5.1 Global Peripheral Arterial Interventional Devices Sale Market Share by Application (2020-2025)
2.5.2 Global Peripheral Arterial Interventional Devices Revenue and Market Share by Application (2020-2025)
2.5.3 Global Peripheral Arterial Interventional Devices Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Peripheral Arterial Interventional Devices Breakdown Data by Company
3.1.1 Global Peripheral Arterial Interventional Devices Annual Sales by Company (2020-2025)
3.1.2 Global Peripheral Arterial Interventional Devices Sales Market Share by Company (2020-2025)
3.2 Global Peripheral Arterial Interventional Devices Annual Revenue by Company (2020-2025)
3.2.1 Global Peripheral Arterial Interventional Devices Revenue by Company (2020-2025)
3.2.2 Global Peripheral Arterial Interventional Devices Revenue Market Share by Company (2020-2025)
3.3 Global Peripheral Arterial Interventional Devices Sale Price by Company
3.4 Key Manufacturers Peripheral Arterial Interventional Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peripheral Arterial Interventional Devices Product Location Distribution
3.4.2 Players Peripheral Arterial Interventional Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Peripheral Arterial Interventional Devices by Geographic Region
4.1 World Historic Peripheral Arterial Interventional Devices Market Size by Geographic Region (2020-2025)
4.1.1 Global Peripheral Arterial Interventional Devices Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Peripheral Arterial Interventional Devices Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Peripheral Arterial Interventional Devices Market Size by Country/Region (2020-2025)
4.2.1 Global Peripheral Arterial Interventional Devices Annual Sales by Country/Region (2020-2025)
4.2.2 Global Peripheral Arterial Interventional Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peripheral Arterial Interventional Devices Sales Growth
4.4 APAC Peripheral Arterial Interventional Devices Sales Growth
4.5 Europe Peripheral Arterial Interventional Devices Sales Growth
4.6 Middle East & Africa Peripheral Arterial Interventional Devices Sales Growth
5 Americas
5.1 Americas Peripheral Arterial Interventional Devices Sales by Country
5.1.1 Americas Peripheral Arterial Interventional Devices Sales by Country (2020-2025)
5.1.2 Americas Peripheral Arterial Interventional Devices Revenue by Country (2020-2025)
5.2 Americas Peripheral Arterial Interventional Devices Sales by Type (2020-2025)
5.3 Americas Peripheral Arterial Interventional Devices Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Arterial Interventional Devices Sales by Region
6.1.1 APAC Peripheral Arterial Interventional Devices Sales by Region (2020-2025)
6.1.2 APAC Peripheral Arterial Interventional Devices Revenue by Region (2020-2025)
6.2 APAC Peripheral Arterial Interventional Devices Sales by Type (2020-2025)
6.3 APAC Peripheral Arterial Interventional Devices Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Peripheral Arterial Interventional Devices by Country
7.1.1 Europe Peripheral Arterial Interventional Devices Sales by Country (2020-2025)
7.1.2 Europe Peripheral Arterial Interventional Devices Revenue by Country (2020-2025)
7.2 Europe Peripheral Arterial Interventional Devices Sales by Type (2020-2025)
7.3 Europe Peripheral Arterial Interventional Devices Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peripheral Arterial Interventional Devices by Country
8.1.1 Middle East & Africa Peripheral Arterial Interventional Devices Sales by Country (2020-2025)
8.1.2 Middle East & Africa Peripheral Arterial Interventional Devices Revenue by Country (2020-2025)
8.2 Middle East & Africa Peripheral Arterial Interventional Devices Sales by Type (2020-2025)
8.3 Middle East & Africa Peripheral Arterial Interventional Devices Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peripheral Arterial Interventional Devices
10.3 Manufacturing Process Analysis of Peripheral Arterial Interventional Devices
10.4 Industry Chain Structure of Peripheral Arterial Interventional Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peripheral Arterial Interventional Devices Distributors
11.3 Peripheral Arterial Interventional Devices Customer
12 World Forecast Review for Peripheral Arterial Interventional Devices by Geographic Region
12.1 Global Peripheral Arterial Interventional Devices Market Size Forecast by Region
12.1.1 Global Peripheral Arterial Interventional Devices Forecast by Region (2026-2031)
12.1.2 Global Peripheral Arterial Interventional Devices Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Peripheral Arterial Interventional Devices Forecast by Type (2026-2031)
12.7 Global Peripheral Arterial Interventional Devices Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Medtronic, Inc.
13.1.1 Medtronic, Inc. Company Information
13.1.2 Medtronic, Inc. Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.1.3 Medtronic, Inc. Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Medtronic, Inc. Main Business Overview
13.1.5 Medtronic, Inc. Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.2.3 BD Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Boston Scientific Corporation
13.3.1 Boston Scientific Corporation Company Information
13.3.2 Boston Scientific Corporation Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.3.3 Boston Scientific Corporation Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boston Scientific Corporation Main Business Overview
13.3.5 Boston Scientific Corporation Latest Developments
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Information
13.4.2 Abbott Laboratories Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.4.3 Abbott Laboratories Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Abbott Laboratories Main Business Overview
13.4.5 Abbott Laboratories Latest Developments
13.5 Cordis
13.5.1 Cordis Company Information
13.5.2 Cordis Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.5.3 Cordis Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Cordis Main Business Overview
13.5.5 Cordis Latest Developments
13.6 Acotec
13.6.1 Acotec Company Information
13.6.2 Acotec Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.6.3 Acotec Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Acotec Main Business Overview
13.6.5 Acotec Latest Developments
13.7 Biotronik
13.7.1 Biotronik Company Information
13.7.2 Biotronik Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.7.3 Biotronik Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Biotronik Main Business Overview
13.7.5 Biotronik Latest Developments
13.8 Terumo Corporation
13.8.1 Terumo Corporation Company Information
13.8.2 Terumo Corporation Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.8.3 Terumo Corporation Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Terumo Corporation Main Business Overview
13.8.5 Terumo Corporation Latest Developments
13.9 Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd.
13.9.1 Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd. Company Information
13.9.2 Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd. Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.9.3 Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd. Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd. Main Business Overview
13.9.5 Shanghai MicroPort Endovascular MedTech锛圙roup锛塁o., Ltd. Latest Developments
13.10 Cook Medical
13.10.1 Cook Medical Company Information
13.10.2 Cook Medical Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.10.3 Cook Medical Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Cook Medical Main Business Overview
13.10.5 Cook Medical Latest Developments
13.11 Lepu Medical
13.11.1 Lepu Medical Company Information
13.11.2 Lepu Medical Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.11.3 Lepu Medical Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Lepu Medical Main Business Overview
13.11.5 Lepu Medical Latest Developments
13.12 Zylox-Tonbridge Medical Technology Co., Ltd.
13.12.1 Zylox-Tonbridge Medical Technology Co., Ltd. Company Information
13.12.2 Zylox-Tonbridge Medical Technology Co., Ltd. Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.12.3 Zylox-Tonbridge Medical Technology Co., Ltd. Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Zylox-Tonbridge Medical Technology Co., Ltd. Main Business Overview
13.12.5 Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
13.13 LeoMed
13.13.1 LeoMed Company Information
13.13.2 LeoMed Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.13.3 LeoMed Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 LeoMed Main Business Overview
13.13.5 LeoMed Latest Developments
13.14 LifeTech Scientific Corporation
13.14.1 LifeTech Scientific Corporation Company Information
13.14.2 LifeTech Scientific Corporation Peripheral Arterial Interventional Devices Product Portfolios and Specifications
13.14.3 LifeTech Scientific Corporation Peripheral Arterial Interventional Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 LifeTech Scientific Corporation Main Business Overview
13.14.5 LifeTech Scientific Corporation Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂